The Potential Therapeutic Application of Simvastatin for Brain Complications and Mechanisms of Action
Pharmaceuticals · 22.06.2023 · 16 (7) · 914
DOI: 10.3390/ph16070914 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 22.06.2023. Verfasst von Yen My Vuu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Medical Genetics, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB …. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 220 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research (CIHR) Project, Children Hospital Research Institute of Manitoba (CHRIM) Operating Grant.
Abstract (Originalsprache)
Statins are common drugs that are clinically used to reduce elevated plasma cholesterol levels. Based on their solubility, statins are considered to be either hydrophilic or lipophilic. Amongst them, simvastatin has the highest lipophilicity to facilitate its ability to cross the blood-brain barrier. Recent studies have suggested that simvastatin could be a promising therapeutic option for different brain complications and diseases ranging from brain tumors (i.e., medulloblastoma and glioblastoma) to neurological disorders (i.e., Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease). Specific mechanisms of disease amelioration, however, are still unclear. Independent studies suggest that simvastatin may reduce the risk of developing certain neurodegenerative disorders. Meanwhile, other studies point towards inducing cell death in brain tumor cell lines. In this review, we outline the potential therapeutic effects of simvastatin on brain complications and review the clinically relevant molecular mechanisms in different cases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry and Medical Genetics, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.
ORCID-Profile: Mojgan Rastegar
Förderung
- CIHR
- Canadian Institutes of Health Research (CIHR) Project
- Children Hospital Research Institute of Manitoba (CHRIM) Operating Grant
- University of Manitoba Research Grant Program (URGP)
- University of Manitoba Collaborative Research Program (UCRP)
Zitieren
APA
Vuu, Y. M., Kadar Shahib, A., & Rastegar, M. (2023). The Potential Therapeutic Application of Simvastatin for Brain Complications and Mechanisms of Action. Pharmaceuticals, 16(7), 914. https://doi.org/10.3390/ph16070914
Vancouver
Vuu YM, Kadar Shahib A, Rastegar M. The Potential Therapeutic Application of Simvastatin for Brain Complications and Mechanisms of Action. Pharmaceuticals. 2023;16(7):914. doi:10.3390/ph16070914
BibTeX
@article{Vuu2023,
author = {Vuu, Yen My and Kadar Shahib, Ashraf and Rastegar, Mojgan},
title = {The Potential Therapeutic Application of Simvastatin for Brain Complications and Mechanisms of Action},
journal = {Pharmaceuticals},
year = {2023},
volume = {16},
number = {7},
pages = {914},
doi = {10.3390/ph16070914}
}
EUVIMED